Livento Group (NUGN) Stock Price, News & Analysis

Company Overview

Livento Group, Inc. engages in the film and television production business. It is also involved in the artificial intelligence and machine learning technology business; development and licensing of Elisee, a software product that can capture data and create predictive behavior based on client inputs that assist the client in establishing its investment portfolio; and real estate finance and development activities. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is headquartered in New York, New York.

Key Stats

• Today's Range: $0.0010 to $0.0013
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.04
• Volume: 12.15 million shs
• Average Volume: 3.95 million shs
• Market Capitalization: $1.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NUGN Stock Analysis - Frequently Asked Questions

How have NUGN shares performed this year?

Livento Group's stock was trading at $0.0034 at the beginning of 2025. Since then, NUGN stock has decreased by 61.8% and is now trading at $0.0013.
View the best growth stocks for 2025 here.

How do I buy shares of Livento Group?

Shares of NUGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Livento Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Livento Group investors own include Palisade Bio (PALI), Meta Platforms (META), Ideanomics (IDEX) and Gold Resource (GORO).

Company Calendar

• Today: 5/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Multi-Sector Conglomerates
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: OTCMKTS:NUGN
• CIK: 1593549
• Web: www.nugene.com
• Phone: 980-432-8241
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,550,000.00
• Net Margins: 43.58%
• Pretax Margin: 0.21%
• Return on Equity: 1.89%
• Return on Assets: 1.73%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.40
• Quick Ratio: 5.40

Sales & Book Value

• Annual Sales: $2.01 million
• Price / Sales: 0.76
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.10 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 1,177,935,000
• Free Float: N/A
• Market Cap: $1.53 million
• Optionable: Not Optionable
• Beta: 7.87